The Fonds de solidarité FTQ Invests $4 Million in Zymeworks Inc. in Support of Québec’s Health Sciences Sector

December 19, 2014

December 19, 2014 – Zymeworks Inc. Montréal and Vancouver – December 19, 2014 – The Fonds de solidarité FTQ, a Québec-based development capital fund, today announced an investment of $4 million in common shares of Zymeworks Inc., a biotherapeutics company focused on the development of best-in-class bi-specific antibodies and antibody drug conjugates (“ADCs”) for the … Continue reading The Fonds de solidarité FTQ Invests $4 Million in Zymeworks Inc. in Support of Québec’s Health Sciences Sector

Versant Ventures Closes $305 Million Healthcare Fund

December 10, 2014

December 10, 2014 – Versant Ventures Venture capital firm to catalyze healthcare investment activities across the country with significant support from leading Canadian investors VANCOUVER, Dec. 10, 2014 /CNW/ – Versant Ventures, a global healthcare investment firm, today announced the close of Versant Venture Capital V L.P., at $305 million US, exceeding its target size … Continue reading Versant Ventures Closes $305 Million Healthcare Fund

Zymeworks Inc. and Merck & Co., Inc. Extend and Expand Bi-specific Antibody Therapeutics Collaboration

December 9, 2014

December 09, 2014 – Zymeworks Inc. Vancouver, Canada (December 9, 2014) – Zymeworks Inc. today announced the extension of a research collaboration with Merck, known as MSD outside the United States and Canada, that was originally announced in August 2011. In addition, Merck gains expanded access to Zymeworks’ proprietary Azymetric™ platform for the development of … Continue reading Zymeworks Inc. and Merck & Co., Inc. Extend and Expand Bi-specific Antibody Therapeutics Collaboration

LGTmedical Announces White-Label mHealth App-Devices for OEMs

December 8, 2014

December 08, 2014 – LionsGate Technologies Inc. (LGTmedical) Cost-effective, software-defined app-devices turn smartphones and tablets into sophisticated vital signs monitors. WASHINGTON, DC – December 8, 2014 – Today at the mHealth Summit, LionsGate Technologies, Inc. (LGTmedical) announced their software-defined app-devices will be available as white-label products for leading medical device manufacturers and healthcare service providers. … Continue reading LGTmedical Announces White-Label mHealth App-Devices for OEMs

BIOLUX RESEARCH ANNOUNCES THAT ORTHOPULSE™ RECEIVES REGULATORY APPROVAL IN CANADA

November 21, 2014

November 21, 2014 – Biolux Research Ltd. VANCOUVER, CANADA / November 21, 2014 – Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is proud to announce that its innovative new product, the OrthoPulse™, has received a Medical Device License from Health Canada and is now commercially available in Canada. The device was approved … Continue reading BIOLUX RESEARCH ANNOUNCES THAT ORTHOPULSE™ RECEIVES REGULATORY APPROVAL IN CANADA

Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing

November 20, 2014

November 20, 2014 – Aequus Pharmaceuticals Inc Aequus Pharmaceuticals Inc. (the “Company” or “Aequus”) is pleased to announce that it has closed a brokered private placement offering (the “Brokered Offering”) of special warrants for approximately C$3.7 million. Cormark Securities Inc. and Clarus Securities Inc. acted as co-lead agents in the Brokered Offering for a syndicate … Continue reading Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing

Early Diagnosis of Pneumonia Critical to Stopping World’s #1 Infectious Killer of Children

November 13, 2014

November 13, 2014 – LionsGate Technologies Inc. (LGTmedical) New software-defined app-device by LionsGate Technologies (LGTmedical) leverages mobile phones and tablets to create pulse oximeters that can quickly and accurately measure key signs of pneumonia severity. VANCOUVER, BC – November 13, 2014 – On the sixth annual World Pneumonia Day, LionsGate Technologies (LGTmedical) joined the Global … Continue reading Early Diagnosis of Pneumonia Critical to Stopping World’s #1 Infectious Killer of Children

SUSTAINABLE BIOENERGY – Genomics adds a new dimension to LNG and biofuels

November 13, 2014 – Genome British Columbia Vancouver, BC – As the province looks for sustainable energy alternatives to help offset the impact of climate change, two sectors are emerging with the potential to fuel economic growth with reduced greenhouse gas emissions. These include natural gas sourced from deep shale formations and biofuels refined from … Continue reading SUSTAINABLE BIOENERGY – Genomics adds a new dimension to LNG and biofuels

Tekmira Provides Corporate Update and Announces Third Quarter 2014 Results

November 6, 2014

November 06, 2014 – Tekmira Pharmaceuticals Corporation Conference Call at 5:00 pm Eastern Time Today VANCOUVER, British Columbia, Nov. 6, 2014 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced its financial and operating results for the third quarter ended September 30, 2014 and provided a … Continue reading Tekmira Provides Corporate Update and Announces Third Quarter 2014 Results

Xenon Pharmaceuticals Announces Pricing of Initial Public Offering

November 4, 2014

November 04, 2014 – Xenon Pharmaceuticals Inc. BURNABY, British Columbia – November 4, 2014 – Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 4,000,000 of its common shares at a price to the public of $9.00 per share. In addition, Xenon Pharmaceuticals has granted … Continue reading Xenon Pharmaceuticals Announces Pricing of Initial Public Offering